RyR1 Structural Alterations Explain Statin-Associated Muscle Dysfunction
December 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Viaskin Peanut
Synonyms :
peanut immunotherapy epicutaneous
Class :
Allergen Immunotherapy
Brand Name :
Viaskin Peanut
Synonyms :
peanut immunotherapy epicutaneous
Class :
Allergen Immunotherapy
Not determined
Awaiting FDA approval for epicutaneous desensitization to protect patients with peanut allergies from severe reactions in the event that they unintentionally come into contact with peanuts
Refer to adult dosing
Actions and Spectrum
When a peanut allergy sufferer is unintentionally exposed, epicutaneous immunotherapy can be used to gradually desensitize and maintain them.
Frequency not defined
None
Black Box Warning
None
Contraindication/Caution:
None
Pregnancy consideration:
Pregnancy category: N/A
Lactation: Excretion into human milk is unknown
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
Peanut immunotherapy epicutaneous involves controlled exposure to peanut allergens through the skin, typically facilitated by a peanut patch. The patch contains specific amounts of peanut protein, usually in the form of peanut extract.
Pharmacodynamics
None
Pharmacokinetics
Limited information available on ADME as drug is pending for FDA approval.
Administration
The administration of peanut immunotherapy is through the epicutaneous route.
Patient information leaflet
Generic Name: peanut immunotherapy epicutaneous
Why do we use peanut immunotherapy epicutaneous?
Peanut immunotherapy epicutaneous (FDA approval pending) is use in the management of peanut allergy.
It also reduces the severity of allergic reactions or prevent them by desensitizing the immune system to peanut allergens.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
